Search

Search Constraints

You searched for: Author/Creator Pollard, Jessica A.

Search Results

1. Gemtuzumab Ozogamicin Improves Event-Free Survival and Reduces Relapse in Pediatric KMT2A-Rearranged AML: Results From the Phase III Children's Oncology Group Trial AAML0531. Issue 28 (1st October 2021)

2. High EVI1 expression is associated with MLL rearrangements and predicts decreased survival in paediatric acute myeloid leukaemia: a report from the children's oncology group. (4th July 2013)

3. Improving Time to Antibiotics for Pediatric Oncology Patients With Suspected Infections: An Emergency Department–Based Quality Improvement Intervention. Issue 1 (January 2018)

4. Outcomes of intensification of induction chemotherapy for children with high‐risk acute myeloid leukemia: A report from the Children's Oncology Group. Issue 12 (1st October 2021)

5. Sorafenib in Combination With Standard Chemotherapy for Children With High Allelic Ratio FLT3/ITD+ Acute Myeloid Leukemia: A Report From the Children's Oncology Group Protocol AAML1031. Issue 18 (20th June 2022)

6. Sorafenib treatment following hematopoietic stem cell transplant in pediatric FLT3/ITD acute myeloid leukemia. Issue 6 (8th February 2015)

7. The prognostic effect of high diagnostic WT1 gene expression in pediatric AML depends on WT1 SNP rs16754 status: Report from the Children's Oncology Group. Issue 1 (16th August 2013)